TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets
Conditions: Neuroendocrine Tumors; Liver Metastases Intervention: Radiation: TheraSpheres Selective Internal Radiation Therapy (SIRT) Sponsors: Imperial College London; Biocompatibles UK Ltd, a BT International group company Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brachytherapy | Brain | Liver | Neurology | Radiation Therapy | Research | Urology & Nephrology